UniProt ID | PTN22_HUMAN | |
---|---|---|
UniProt AC | Q9Y2R2 | |
Protein Name | Tyrosine-protein phosphatase non-receptor type 22 | |
Gene Name | PTPN22 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 807 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Acts as negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules. [PubMed: 16461343] | |
Protein Sequence | MDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSGTESQAKHCIPEKNHTLQADSYSPNLPKSTTKAAKMMNQQRTKMEIKESSSFDFRTSEISAKEELVLHPAKSSTSFDFLELNYSFDKNADTTMKWQTKAFPIVGEPLQKHQSLDLGSLLFEGCSNSKPVNAAGRYFNSKVPITRTKSTPFELIQQRETKEVDSKENFSYLESQPHDSCFVEMQAQKVMHVSSAELNYSLPYDSKHQIRNASNVKHHDSSALGVYSYIPLVENPYFSSWPPSGTSSKMSLDLPEKQDGTVFPSSLLPTSSTSLFSYYNSHDSLSLNSPTNISSLLNQESAVLATAPRIDDEIPPPLPVRTPESFIVVEEAGEFSPNVPKSLSSAVKVKIGTSLEWGGTSEPKKFDDSVILRPSKSVKLRSPKSELHQDRSSPPPPLPERTLESFFLADEDCMQAQSIETYSTSYPDTMENSTSSKQTLKTPGKSFTRSKSLKILRNMKKSICNSCPPNKPAESVQSNNSSSFLNFGFANRFSKPKGPRNPPPTWNI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Ubiquitination | DQREILQKFLDEAQS CHHHHHHHHHHHHHH | 44.44 | - | |
17 | Ubiquitination | FLDEAQSKKITKEEF HHHHHHHCCCCHHHH | 35.79 | - | |
17 | Ubiquitination | FLDEAQSKKITKEEF HHHHHHHCCCCHHHH | 35.79 | - | |
18 | Ubiquitination | LDEAQSKKITKEEFA HHHHHHCCCCHHHHH | 61.94 | - | |
18 | Ubiquitination | LDEAQSKKITKEEFA HHHHHHCCCCHHHHH | 61.94 | - | |
21 | Ubiquitination | AQSKKITKEEFANEF HHHCCCCHHHHHHHH | 59.73 | - | |
21 | Ubiquitination | AQSKKITKEEFANEF HHHCCCCHHHHHHHH | 59.73 | - | |
30 | Ubiquitination | EFANEFLKLKRQSTK HHHHHHHHHHHCCCC | 58.23 | - | |
32 | Ubiquitination | ANEFLKLKRQSTKYK HHHHHHHHHCCCCCC | 46.97 | - | |
32 | Ubiquitination | ANEFLKLKRQSTKYK HHHHHHHHHCCCCCC | 46.97 | - | |
35 | Phosphorylation | FLKLKRQSTKYKADK HHHHHHCCCCCCCCC | 30.79 | 18056643 | |
43 | Phosphorylation | TKYKADKTYPTTVAE CCCCCCCCCCCCHHC | 34.97 | 30242111 | |
44 | Phosphorylation | KYKADKTYPTTVAEK CCCCCCCCCCCHHCC | 12.34 | 30242111 | |
46 | Phosphorylation | KADKTYPTTVAEKPK CCCCCCCCCHHCCCC | 24.40 | 30242111 | |
47 | Phosphorylation | ADKTYPTTVAEKPKN CCCCCCCCHHCCCCC | 17.14 | 30242111 | |
51 | Ubiquitination | YPTTVAEKPKNIKKN CCCCHHCCCCCCCCC | 52.10 | - | |
61 | Ubiquitination | NIKKNRYKDILPYDY CCCCCCCCCCCCCCC | 34.75 | - | |
61 | Ubiquitination | NIKKNRYKDILPYDY CCCCCCCCCCCCCCC | 34.75 | - | |
84 | Phosphorylation | TSDEDSSYINANFIK ECCCCCCCCCCCEEC | 11.35 | - | |
142 | Phosphorylation | GKKKCERYWAEPGEM CHHHHHHHCCCCCEE | 6.15 | 29116813 | |
166 | Ubiquitination | SCEAEKRKSDYIIRT EEEEHHHCCCEEEEE | 59.76 | - | |
166 | Ubiquitination | SCEAEKRKSDYIIRT EEEEHHHCCCEEEEE | 59.76 | - | |
167 | Phosphorylation | CEAEKRKSDYIIRTL EEEHHHCCCEEEEEE | 39.41 | 23532336 | |
169 | Phosphorylation | AEKRKSDYIIRTLKV EHHHCCCEEEEEEEE | 12.82 | 29457462 | |
173 | Phosphorylation | KSDYIIRTLKVKFNS CCCEEEEEEEEEECC | 22.11 | - | |
260 | Ubiquitination | PENFSVFSLIREMRT CCCCCHHHHHHHHHH | 22.26 | - | |
300 | Ubiquitination | QMDVIRDKHSGTESQ HHHHHHCCCCCCHHH | 29.80 | - | |
309 | Ubiquitination | SGTESQAKHCIPEKN CCCHHHHHHCCCCCC | 31.22 | - | |
309 | Ubiquitination | SGTESQAKHCIPEKN CCCHHHHHHCCCCCC | 31.22 | - | |
315 | Ubiquitination | AKHCIPEKNHTLQAD HHHCCCCCCCEECCC | 48.99 | - | |
318 | Phosphorylation | CIPEKNHTLQADSYS CCCCCCCEECCCCCC | 29.93 | 27080861 | |
323 | Phosphorylation | NHTLQADSYSPNLPK CCEECCCCCCCCCCH | 30.44 | 23401153 | |
324 | Phosphorylation | HTLQADSYSPNLPKS CEECCCCCCCCCCHH | 28.79 | 28450419 | |
325 | Phosphorylation | TLQADSYSPNLPKST EECCCCCCCCCCHHH | 15.97 | 23401153 | |
330 | Ubiquitination | SYSPNLPKSTTKAAK CCCCCCCHHHHHHHH | 64.70 | - | |
337 | Acetylation | KSTTKAAKMMNQQRT HHHHHHHHHHHHHHH | 43.47 | 25953088 | |
337 | Ubiquitination | KSTTKAAKMMNQQRT HHHHHHHHHHHHHHH | 43.47 | - | |
341 | Ubiquitination | KAAKMMNQQRTKMEI HHHHHHHHHHHCHHH | 19.08 | - | |
345 | Ubiquitination | MMNQQRTKMEIKESS HHHHHHHCHHHHHCC | 36.40 | - | |
351 | Phosphorylation | TKMEIKESSSFDFRT HCHHHHHCCCCCCCC | 26.70 | 27251275 | |
352 | Phosphorylation | KMEIKESSSFDFRTS CHHHHHCCCCCCCCC | 35.80 | 27251275 | |
353 | Phosphorylation | MEIKESSSFDFRTSE HHHHHCCCCCCCCCC | 37.81 | 27251275 | |
356 | Ubiquitination | KESSSFDFRTSEISA HHCCCCCCCCCCCCC | 9.64 | - | |
364 | Acetylation | RTSEISAKEELVLHP CCCCCCCCEEEEECC | 44.95 | 19822837 | |
364 | Ubiquitination | RTSEISAKEELVLHP CCCCCCCCEEEEECC | 44.95 | - | |
373 | Acetylation | ELVLHPAKSSTSFDF EEEECCCCCCCCCEE | 49.76 | 19822847 | |
374 | Ubiquitination | LVLHPAKSSTSFDFL EEECCCCCCCCCEEE | 40.74 | - | |
374 | Phosphorylation | LVLHPAKSSTSFDFL EEECCCCCCCCCEEE | 40.74 | 26074081 | |
375 | Phosphorylation | VLHPAKSSTSFDFLE EECCCCCCCCCEEEE | 27.62 | 26074081 | |
376 | Phosphorylation | LHPAKSSTSFDFLEL ECCCCCCCCCEEEEE | 40.27 | 26074081 | |
377 | Phosphorylation | HPAKSSTSFDFLELN CCCCCCCCCEEEEEE | 25.43 | 26074081 | |
386 | Ubiquitination | DFLELNYSFDKNADT EEEEEEEEECCCCCC | 26.37 | - | |
393 | Ubiquitination | SFDKNADTTMKWQTK EECCCCCCCCEEECC | 26.78 | - | |
396 | Ubiquitination | KNADTTMKWQTKAFP CCCCCCCEEECCCCC | 33.77 | - | |
400 | Ubiquitination | TTMKWQTKAFPIVGE CCCEEECCCCCCCCC | 32.69 | - | |
406 | Ubiquitination | TKAFPIVGEPLQKHQ CCCCCCCCCCCHHCC | 31.37 | - | |
411 | Ubiquitination | IVGEPLQKHQSLDLG CCCCCCHHCCCCCHH | 51.82 | - | |
411 | Ubiquitination | IVGEPLQKHQSLDLG CCCCCCHHCCCCCHH | 51.82 | - | |
414 | Phosphorylation | EPLQKHQSLDLGSLL CCCHHCCCCCHHHHH | 24.46 | 20058876 | |
419 | Phosphorylation | HQSLDLGSLLFEGCS CCCCCHHHHHHCCCC | 29.24 | 28450419 | |
429 | Ubiquitination | FEGCSNSKPVNAAGR HCCCCCCCCCCCHHH | 58.18 | - | |
441 | Ubiquitination | AGRYFNSKVPITRTK HHHHCCCCCCCCCCC | 53.81 | - | |
447 | Phosphorylation | SKVPITRTKSTPFEL CCCCCCCCCCCHHHH | 22.24 | 23401153 | |
448 | Ubiquitination | KVPITRTKSTPFELI CCCCCCCCCCHHHHH | 49.38 | - | |
449 | Phosphorylation | VPITRTKSTPFELIQ CCCCCCCCCHHHHHH | 40.47 | 23401153 | |
450 | Phosphorylation | PITRTKSTPFELIQQ CCCCCCCCHHHHHHC | 33.29 | 28122231 | |
451 | Ubiquitination | ITRTKSTPFELIQQR CCCCCCCHHHHHHCC | 28.01 | - | |
461 | Ubiquitination | LIQQRETKEVDSKEN HHHCCCCCCCCCHHC | 51.49 | - | |
466 | Ubiquitination | ETKEVDSKENFSYLE CCCCCCCHHCCHHHH | 52.81 | - | |
493 | Phosphorylation | AQKVMHVSSAELNYS CCEEEEECHHHCCCC | 14.78 | 26434552 | |
494 | Phosphorylation | QKVMHVSSAELNYSL CEEEEECHHHCCCCC | 25.36 | 26434552 | |
499 | Phosphorylation | VSSAELNYSLPYDSK ECHHHCCCCCCCCCH | 24.98 | 28796482 | |
500 | Phosphorylation | SSAELNYSLPYDSKH CHHHCCCCCCCCCHH | 23.07 | 28796482 | |
503 | Phosphorylation | ELNYSLPYDSKHQIR HCCCCCCCCCHHHHC | 37.84 | 27080861 | |
505 | Phosphorylation | NYSLPYDSKHQIRNA CCCCCCCCHHHHCCC | 26.62 | 27080861 | |
506 | Ubiquitination | YSLPYDSKHQIRNAS CCCCCCCHHHHCCCH | 36.31 | - | |
526 | Phosphorylation | DSSALGVYSYIPLVE CCCCCCEEEECCCCC | 8.24 | - | |
527 | Phosphorylation | SSALGVYSYIPLVEN CCCCCEEEECCCCCC | 17.74 | - | |
528 | Phosphorylation | SALGVYSYIPLVENP CCCCEEEECCCCCCC | 6.72 | - | |
536 | Phosphorylation | IPLVENPYFSSWPPS CCCCCCCCCCCCCCC | 27.89 | - | |
550 | Phosphorylation | SGTSSKMSLDLPEKQ CCCCCCEECCCCCCC | 23.59 | 28348404 | |
585 | Ubiquitination | YNSHDSLSLNSPTNI CCCCCCCCCCCCCCH | 29.47 | - | |
592 | Ubiquitination | SLNSPTNISSLLNQE CCCCCCCHHHHHCHH | 3.05 | - | |
594 | Ubiquitination | NSPTNISSLLNQESA CCCCCHHHHHCHHCH | 32.83 | - | |
609 | Ubiquitination | VLATAPRIDDEIPPP HHHCCCCCCCCCCCC | 8.35 | - | |
635 | Phosphorylation | VEEAGEFSPNVPKSL EEECCCCCCCCCCCH | 15.97 | 28348404 | |
640 | Ubiquitination | EFSPNVPKSLSSAVK CCCCCCCCCHHCCEE | 60.80 | - | |
647 | Ubiquitination | KSLSSAVKVKIGTSL CCHHCCEEEEECCCC | 37.21 | - | |
649 | Ubiquitination | LSSAVKVKIGTSLEW HHCCEEEEECCCCCC | 29.69 | - | |
653 | Phosphorylation | VKVKIGTSLEWGGTS EEEEECCCCCCCCCC | 21.05 | - | |
663 | Ubiquitination | WGGTSEPKKFDDSVI CCCCCCCCCCCCCEE | 63.12 | - | |
664 | Ubiquitination | GGTSEPKKFDDSVIL CCCCCCCCCCCCEEE | 65.82 | - | |
675 | Ubiquitination | SVILRPSKSVKLRSP CEEECCCCCEECCCC | 63.05 | - | |
684 | Phosphorylation | VKLRSPKSELHQDRS EECCCCCHHHCCCCC | 49.10 | 28464451 | |
691 | Phosphorylation | SELHQDRSSPPPPLP HHHCCCCCCCCCCCC | 56.33 | 23401153 | |
692 | Phosphorylation | ELHQDRSSPPPPLPE HHCCCCCCCCCCCCH | 42.17 | 23911959 | |
715 | Ubiquitination | ADEDCMQAQSIETYS CCHHHHHCCCCEEEC | 4.35 | - | |
741 | Phosphorylation | SSKQTLKTPGKSFTR CCCCCCCCCCCCCCH | 40.15 | 23532336 | |
744 | Ubiquitination | QTLKTPGKSFTRSKS CCCCCCCCCCCHHHH | 43.53 | - | |
745 | Phosphorylation | TLKTPGKSFTRSKSL CCCCCCCCCCHHHHH | 37.45 | 30622161 | |
747 | Phosphorylation | KTPGKSFTRSKSLKI CCCCCCCCHHHHHHH | 40.92 | 30622161 | |
749 | Phosphorylation | PGKSFTRSKSLKILR CCCCCCHHHHHHHHH | 24.44 | 30622161 | |
751 | Phosphorylation | KSFTRSKSLKILRNM CCCCHHHHHHHHHHC | 35.82 | 30622161 | |
770 | Ubiquitination | CNSCPPNKPAESVQS HHCCCCCCCCHHHCC | 51.91 | - | |
793 | Phosphorylation | FGFANRFSKPKGPRN CCCCCCCCCCCCCCC | 44.82 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
35 | S | Phosphorylation | Kinase | PKCD | Q05655 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
35 | S | Phosphorylation |
| 18056643 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTN22_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
152700 | Systemic lupus erythematosus (SLE) | |||||
222100 | Diabetes mellitus, insulin-dependent (IDDM) | |||||
180300 | Rheumatoid arthritis (RA) | |||||
193200 | Vitiligo (VTLG) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases."; Yu X., Sun J.P., He Y., Guo X., Liu S., Zhou B., Hudmon A.,Zhang Z.Y.; Proc. Natl. Acad. Sci. U.S.A. 104:19767-19772(2007). Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-294 IN COMPLEX WITHINHIBITOR, FUNCTION, PHOSPHORYLATION AT SER-35, AND MUTAGENESIS OFSER-35 AND THR-36. |